PT697876E - Enxerto de timo xenogenio - Google Patents

Enxerto de timo xenogenio

Info

Publication number
PT697876E
PT697876E PT94917424T PT94917424T PT697876E PT 697876 E PT697876 E PT 697876E PT 94917424 T PT94917424 T PT 94917424T PT 94917424 T PT94917424 T PT 94917424T PT 697876 E PT697876 E PT 697876E
Authority
PT
Portugal
Prior art keywords
xenogenium
timo
enzyme
donor
engraftment
Prior art date
Application number
PT94917424T
Other languages
English (en)
Inventor
David H Sachs
Megan Sykes
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Publication of PT697876E publication Critical patent/PT697876E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/26Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39541Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/17Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515Animal cells
    • A61K2039/5156Animal cells expressing foreign proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Glass Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Prostheses (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
PT94917424T 1993-05-17 1994-05-16 Enxerto de timo xenogenio PT697876E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6294693A 1993-05-17 1993-05-17
US16391293A 1993-12-07 1993-12-07

Publications (1)

Publication Number Publication Date
PT697876E true PT697876E (pt) 2002-11-29

Family

ID=26742900

Family Applications (1)

Application Number Title Priority Date Filing Date
PT94917424T PT697876E (pt) 1993-05-17 1994-05-16 Enxerto de timo xenogenio

Country Status (10)

Country Link
EP (1) EP0697876B1 (pt)
JP (1) JP3553941B2 (pt)
AT (1) ATE222111T1 (pt)
AU (1) AU694120B2 (pt)
CA (1) CA2161797A1 (pt)
DE (1) DE69431184T2 (pt)
DK (1) DK0697876T3 (pt)
ES (1) ES2179846T3 (pt)
PT (1) PT697876E (pt)
WO (1) WO1994026285A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL155414A0 (en) * 2000-10-13 2003-11-23 Univ Monash Disease prevention by reactivation of the thymus
CA2462046A1 (en) * 2000-10-13 2002-04-18 Monash University Improvement of graft acceptance through manipulation of thymic regeneration

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5087570A (en) * 1988-05-10 1992-02-11 Weissman Irving L Homogeneous mammalian hematopoietic stem cell composition

Also Published As

Publication number Publication date
CA2161797A1 (en) 1994-11-24
JP3553941B2 (ja) 2004-08-11
EP0697876A1 (en) 1996-02-28
EP0697876B1 (en) 2002-08-14
DE69431184T2 (de) 2003-03-27
ES2179846T3 (es) 2003-02-01
ATE222111T1 (de) 2002-08-15
JPH09500364A (ja) 1997-01-14
AU6915794A (en) 1994-12-12
EP0697876A4 (en) 1997-09-10
DK0697876T3 (da) 2002-09-09
AU694120B2 (en) 1998-07-16
DE69431184D1 (en) 2002-09-19
WO1994026285A1 (en) 1994-11-24

Similar Documents

Publication Publication Date Title
DE59905954D1 (de) Dialkylfumarate zur behandlung von autoimmunerkrankungen
ES2179077T3 (es) Acido glutamico decarboxilasa clonada.
DK1063945T3 (da) Tvedelt prostetisk graft
ATE393831T1 (de) Zusammensetzung zur in vivo erzeugung von therapeutischen produkten
GEP20022648B (en) Method for Inducing T Cell Tolerance to a Tissue or Organ Graft
AU3065989A (en) Polypeptide compounds having growth hormone releasing activity
ES2170096T3 (es) Uso de lineas celulares fetales neuroderivadas para terapia de trasplantes.
BR0203650A (pt) Estentor de auto-articulação
ATE76294T1 (de) Galanthamin oder dessen analoge zur behandlung der alzheimerschen krankheit.
FR2662698B1 (pt)
PT941329E (pt) Metodo para prevenir a rejeicao de enxertos em transplantacao e para produzir uma celula-hospedeiro para terapia genetica universal utilizando activacao de linfocitos (lag-3)
DE3875306D1 (de) Immunosuppression bei der auf immunotoxin basierten behandlung von menschen.
GR3008170T3 (pt)
DK0697876T3 (da) Xenograftthymus
IL131478A0 (en) Methods for treatment of scar tissue
EP1637146A3 (en) Ex vivo treatment of allogeneic and xenogeneic T-cells with gp39 antagonists
PT925064E (pt) 5-androsteno-3beta,17alfa-diol como um inibidor do crescimento tumoral
GR3001850T3 (en) Expellants of phytopathogenic microbes
EP1048298A3 (en) Mixed chimerism and tolerance
GB9723824D0 (en) Cytostatic agents
UA32660A (uk) Підкладка до дерматомів
AU130339S (en) Meditation pyramid
ATE283063T1 (de) Allogene und xenogene transplantation
AU133233S (en) Seedling propagation tray